Home Therapy Mouth and upper respiratory tract
Home Therapy Mouth and upper respiratory tract

herpes simplex stomatitis, herpes simplex labialis, orofaryngeale herpes simplex, mucocutane herpes simplex

Advices

≥ 18 years

Indications: Immuuncompetent
Priority Medication Remarks
Medication:

valaciclovir po 500mg 2dd minimum 5 days

or

aciclovir iv 5mg/kg 3dd minimum 5 days
Remarks:

Alleen behandelen bij ernstige infectie
≥ 18 years

Indications: Bij immuungecompromitteerden
Priority Medication Remarks
Medication:

valaciclovir po 1000mg 2dd minimum 5 days

or

aciclovir iv 5mg/kg 3dd minimum 5 days
Remarks:

Altijd behandelen 

Sources

  1. Pubmed.gov publication # 18541820

    Cernik et al., The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008 Jun 9;168(11):1137-44.

  2. Pubmed.gov publication # 7036816

    Wade et al., Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982 Mar;96(3):265-9.

  3. Pubmed.gov publication # 7048914

    Meyers et al., Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. The American Journal of Medicine 1982;73(1A): 229–35.

  4. https://kennisbank.knmp.nl/
Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-173711.6
Updated: 03/29/2024 - 15:50
Status: Published